Drug resistance study of Mycobacterium tuberculosis in Canada, February 1,1993 to January 31, 1994

Citation
E. Farzad et al., Drug resistance study of Mycobacterium tuberculosis in Canada, February 1,1993 to January 31, 1994, CAN J PUBL, 91(5), 2000, pp. 366-370
Citations number
21
Categorie Soggetti
Public Health & Health Care Science
Journal title
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
ISSN journal
00084263 → ACNP
Volume
91
Issue
5
Year of publication
2000
Pages
366 - 370
Database
ISI
SICI code
0008-4263(200009/10)91:5<366:DRSOMT>2.0.ZU;2-Q
Abstract
Objective: To estimate the prevalence of resistance of Mycobacterium tuberc ulosis to first-line, antituberculosis drugs in Canada Methods: M. tuberculosis isolates from one third of all culture-positive tu berculosis (TB) diagnosed between February 1, 1933 to January 31, 1994 in C anada were collected prospectively. Proportion of drug-resistant isolates a nd the factors related to drug resistance; were measured. Results: Of 458 study cases, 40 (8.7%) had: resistance to at least one firs t-line antituberculosis drug, of which 5.9% had mono-resistance, 0.7% had m ultidrug-resistance(MDR-TB) - i.e., resistance to at least isoniazid and ri fampin and 2.2% had other patterns. The overall prevalence of resistance am ong the foreign-born cases was 10.6% with the highest level among those who resided in Canada for less than four years (15.5%). Conclusions: Canada has a relatively low prevalence of antituberculosis dru g resistance; and a very low prevalence of MDR-TB. Some new immigrants to C anada may be nr higher risk for drug resistance and their initial treatment s needs to be tailored accordingly.